Skip to main content

Juan Manuel Pericàs Pulido

Institutions of which they are part

Main researcher
Liver Diseases
Vall Hebron Institut de Recerca

Juan Manuel Pericàs Pulido

Institutions of which they are part

Main researcher
Liver Diseases
Vall Hebron Institut de Recerca

Research lines

Metabolisme hepàtic i infeccions (LivMI)

Epidemiologia del fetge gras no alcohòlic, biomarcadors i nous tractament

Infeccions malaltia hepàtica avançada

IP: Juan Manuel Pericàs Pulido

Projects

ARTEMIs: AcceleRating the Translation of virtual twins towards a pErsonalised Management of fatty lIver patients

IP: José Raul Herance Camacho
Collaborators: Beatriz Minguez Rosique, Clara Ramírez Serra, Cristina Gamez Cenzano, Juan Manuel Pericàs Pulido, Nuria Roson Gradaille, Andreea Ciudin Mihai, Alberto Roque Pérez, Queralt Martin Saladich, Maria Nazarena Pizzi, Ramón Vilallonga Puy, Enrique Franky Vargas, Carolina Aparicio Gomez
Funding agency: EUROPEAN COMMISSION
Funding: 724000
Reference: ARTEMIS_HE-HLTH2023
Duration: 01/01/2024 - 31/12/2027

Patient-derived liver biopsy-organoids for personalized medicine in NAFLD (non-alcoholic fatty liver disease): towards real time assessment of drug response (B-Org)

IP: Juan Manuel Pericàs Pulido
Collaborators: -
Funding agency: Fundació Institut Bioenginyeria de Catalunya
Funding: 0.01
Reference: IBEC/2022/PERICAS
Duration: 02/01/2023 - 18/11/2024

Proyecto de formación integral en enfermedad hepática crónica avanzada

IP: Juan Manuel Pericàs Pulido
Collaborators: Miriam Izquierdo Sans
Funding agency: Instituto de Salud Carlos III
Funding: 65000
Reference: CM23/00251
Duration: 02/01/2024 - 01/01/2026

Caracterización de las claves fisiopatológicas y fenotipos de la enfermedad del hígado graso metabólica con ingesta moderada de alcohol para identificar nuevas terapias (ReLiveR).

IP: Meritxell Ventura Cots
Collaborators: Immaculada Raurell Saborit, Juan Manuel Pericàs Pulido, Laura Puente Ramo, Ares Aurora Villagrasa Vilella, Caracterización de las claves fisiopatológicas y fenotipos de la enfermedad del hígado graso metabólica con ingesta moderada de , Maria de la Serra Cusidó Sabidó, Maria Martínez Gómez, Alba Maria Jiménez Masip
Funding agency: Instituto de Salud Carlos III
Funding: 183920
Reference: PI22/01770
Duration: 01/01/2023 - 31/12/2025

Related news

The meetings served to share advances in translational research and consolidate international scientific alliances in the study of liver diseases

The consensus establishes recommendations that could correct the current disparities related to muscle mass, weight and height and would allow for more precise prioritization of patients who require transplants more urgently.

Using computed tomography (CT), with or without contrast, it is possible to perform an accurate and safe detection of the disease without the need for biopsies and avoiding the limitations of other non-invasive diagnostic tools.

Related professionals

Sofia Muñoz Del Rio

Sofia Muñoz Del Rio

Administrative Assistant
Accounting and Revenue Unit
Finance Directorate
Read more
Miriam Cristine Vah Machado

Miriam Cristine Vah Machado

Postdoctoral researcher
Clinical Research/Innovation in Pneumonia & Sepsis (CRIPS)
Read more
Clara Roig Rabada

Clara Roig Rabada

Research assistant
Research Group of Physical Medicine and Rehabilitation
Read more
Aldo Di  Vito

Aldo Di Vito

Predoctoral researcher
Translational Molecular Pathology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.